Open Orphan starts trials on nasal spray Covid-19 vaccines
Trials have begun on next-generation vaccine, says Cathal Friel, executive chairman of Irish pharma digital services firm
Open Orphan has started trials on the next generation of Covid-19 vaccines, according to Cathal Friel, its founder.
The executive chairman and co-founder of the Irish pharmaceutical services company said it had begun phase one trials on a new Covid-19 nasal spray vaccine from US company Codagenix.
The Covi-Vac vaccine comes as a single dose nasal delivery spray and the clinical trial is being conducted by a subsidiary of Open Orphan’s in London called Hvivo....
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team
New Covid-19 condition adds to worries for expectant mothers
The news that recent stillbirths are associated with Covid-19 placentitis has reignited the debate on why mums-to-be are at the bottom of the vaccination priority list
Potential use of rapid antigen tests in workplaces and schools to be assessed
Speedy tests for virus could be used alongside the state’s PCR testing programme as country aims for safer eventual reopening
‘The next few weeks will give us hope if we can hang in there’
There are still some clouds on the horizon with the threat of new variants, but there is also hope as health workers report real benefits from the rollout of the Covid-19 vaccines